A molecular biologist by training and an experienced biotech entrepreneur, Dr. Blanc
also helped biotech and pharma clients with R&D, commercial and strategy issues as associate partner with the business consultants McKinsey & Company.
13 years in the pharmaceutical and biotech industry, he
has worked at the interface between strategy, research and development management, business development and operational delivery.
Antony, who also heads Synosia's Basel operation, most recently served as head of biopharma for Syngenta, a world leading agribusiness based in Basel, where he built a pipeline of eight projects within 24 months.
Previously, he was vice president of business development at Synt:em in France where he established strategic alliances and out-licensed the company's technologies and products.
Antony earned his bachelor's of science degree in biochemistry with a minor in biotechnology and his doctorate in molecular biology from McGill University in Montreal, Canada.